Our results indicate that OGR1 has a key role in supporting the expansion of T cells during autoimmunity, providing the proof of concept that this molecule could be a novel target for therapeutic intervention in T cell-mediated autoimmune diseases such as MS. The gene discussed is GPR68; the disease is Autoimmunity.